COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 155 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $349,000 | -50.7% | 20,008 | -43.4% | 0.00% | -50.0% |
| Q1 2022 | $708,000 | +247.1% | 35,328 | +239.7% | 0.00% | +100.0% |
| Q3 2021 | $204,000 | -19.0% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $252,000 | +2.0% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $247,000 | +20.5% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $205,000 | +0.5% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $204,000 | -28.7% | 10,400 | -51.9% | 0.00% | 0.0% |
| Q2 2019 | $286,000 | +29.4% | 21,600 | +63.6% | 0.00% | 0.0% |
| Q1 2019 | $221,000 | +25.6% | 13,200 | +22.2% | 0.00% | 0.0% |
| Q4 2018 | $176,000 | -20.4% | 10,800 | -18.2% | 0.00% | 0.0% |
| Q3 2018 | $221,000 | -32.8% | 13,200 | -2.2% | 0.00% | -50.0% |
| Q2 2018 | $329,000 | -2.7% | 13,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $338,000 | +96.5% | 13,500 | +33.7% | 0.00% | 0.0% |
| Q1 2016 | $172,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,887,332 | $34,840,000 | 5.65% |
| SECTORAL ASSET MANAGEMENT INC | 1,426,862 | $26,340,000 | 3.29% |
| Eventide Asset Management | 2,207,610 | $40,752,000 | 2.12% |
| Rock Springs Capital Management LP | 1,885,729 | $34,811,000 | 1.58% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 460,000 | $8,492,000 | 1.11% |
| Cormorant Asset Management, LP | 300,000 | $5,538,000 | 0.58% |
| HIGHLAND CAPITAL MANAGEMENT LP | 579,234 | $10,693,000 | 0.49% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,389,863 | $25,657,000 | 0.39% |
| NBW CAPITAL LLC | 69,050 | $1,275,000 | 0.34% |
| NEXT CENTURY GROWTH INVESTORS LLC | 144,972 | $2,676,000 | 0.33% |